Summary & Overview
HCPCS G8696: Antithrombotic Therapy Prescribed at Discharge
HCPCS Level II code G8696 denotes documentation that antithrombotic therapy is prescribed at hospital discharge. Nationally, tracking discharge prescriptions for antithrombotic agents is critical for reducing readmissions and preventing post-discharge thrombotic events after cardiac, vascular, or medical admissions. Clear capture of this measure supports care transitions, quality reporting, and payer program management.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical purpose and its relevance to transitions-of-care workflows. The publication outlines common benchmarking approaches, expected documentation requirements for billing and quality programs, and recent policy developments affecting discharge medication reconciliation and antithrombotic prescribing.
This summary provides clinicians, revenue cycle managers, and policy stakeholders with the clinical context, typical sites of service, and the types of benchmarks and reporting measures tied to G8696. Data not available in the input for specific modifiers, associated taxonomies, ICD-10 linkage, related billing codes, and payer-specific billing edits are noted where applicable.
Billing Code Overview
HCPCS Level II code G8696 represents antithrombotic therapy prescribed at discharge. This code captures the documentation that a patient discharged from an inpatient stay or observation encounter has been prescribed an antithrombotic medication to reduce the risk of thrombotic events.
-
Service type: Prescription and discharge medication management
-
Typical site of service: Hospital inpatient or observation discharge
Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old male admitted with acute ischemic stroke or acute coronary syndrome who receives inpatient treatment (thrombolysis, percutaneous coronary intervention, or anticoagulation for atrial fibrillation). At hospital discharge, the treating clinician documents an antithrombotic medication plan and prescribes therapy intended to reduce recurrent thromboembolic events. The clinical workflow includes medication reconciliation, assessment of bleeding risk versus thrombotic risk, selection of an appropriate antiplatelet or anticoagulant agent, patient and caregiver education, and generation of a discharge prescription and instructions. Nursing and pharmacy perform counseling on dosing, monitoring (for example INR for warfarin), drug interactions, and follow-up appointments. Documentation in the discharge summary records the antithrombotic therapy prescribed and rationale, which supports billing HCPCS Level II code G8696 for antithrombotic therapy prescribed at discharge.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
24 | Unrelated evaluation and management service by the same physician during a postoperative period | Use if antithrombotic prescription is documented during a postoperative period for an unrelated issue |